Publications by authors named "Tatsuya Asuka"

Cell polarity, the asymmetric distribution of proteins and organelles, is permanently or transiently established in various cell types and plays an important role in many physiological events. epidermal growth factor receptor substrate 15 homology domain-binding protein 1-like 1 (EHBP1L1) is an adapter protein that is localized on recycling endosomes and regulates apical-directed transport in polarized epithelial cells. However, the role of EHBP1L1 in nonepithelial cells, remains unknown.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how genetic and environmental factors influence glycosylation changes in specific glycoproteins, which are biomarkers for liver fibrosis and cancer.
  • Researchers used serum samples from twin pairs, with one twin diagnosed with liver or pancreatic diseases, to analyze correlations in glycoprotein levels.
  • Findings indicate that while glycoprotein levels are affected by genetics, the specific changes in glycan structures are more influenced by environmental factors such as the presence of disease.
View Article and Find Full Text PDF

Mac-2 binding protein (Mac-2bp) is a serum glycoprotein that contains seven N-glycans, and Mac-2bp serum levels are increased in patients with several types of cancer and liver disease. Mac-2bp glycosylation isomer has been applied as a clinical biomarker of several diseases, including liver fibrosis. In the present study, we identified fucosylated Mac-2bp in the conditioned medium of cancer cells resistant to anticancer therapies using glycoproteomic analyses.

View Article and Find Full Text PDF

We previously demonstrated that Mac-2 binding protein (M2BP) is a useful biomarker for nonalcoholic fatty liver disease (NAFLD), particularly NAFLD fibrosis prediction. In the present study, we investigated the prognostic value of M2BP in patients with NAFLD. A total of 506 patients with biopsy-confirmed NAFLD from 2002 to 2013 were enrolled in this study in Japan.

View Article and Find Full Text PDF
Article Synopsis
  • Hepatitis B virus (HBV) can lead to serious conditions like acute and chronic hepatitis and even hepatocellular carcinoma (HCC), necessitating regular monitoring for high-risk patients.
  • Current treatments for chronic hepatitis B are challenging to discontinue, and while serum HBV-DNA is the only reliable biomarker for high-risk HCC groups, other clinical biomarkers like alpha-fetoprotein (AFP) are used.
  • Glycosylation, a protein modification linked to various diseases, may offer new therapeutic options for HBV, as it influences HBV infection dynamics and could lead to novel diagnostics and treatments.
View Article and Find Full Text PDF

Receptor interacting protein kinase 1 (RIPK1) is a cytosolic multidomain protein that controls cell life and death. While RIPK1 promotes cell death through its kinase activity, it also functions as a scaffold protein to promote cell survival by inhibiting FADD-caspase 8-dependent apoptosis and RIPK3-MLKL-dependent necroptosis. This pro-survival function is highlighted by excess cell death and perinatal lethality in Ripk1 mice.

View Article and Find Full Text PDF

Fucosylated haptoglobin is a well-established glyco-biomarker of pancreatic cancer. We recently established a novel anti-glycan antibody (10-7G mAb) that specifically recognizes fucosylated haptoglobins, including prohaptoglobin (proHpt). Serum concentrations of the 10-7G value, as measured by ELISA, were increased in patients with pancreatic cancer relative to the healthy controls.

View Article and Find Full Text PDF

: Mac-2 binding protein (M2BP) is a highly glycosylated secreted glycoprotein that is involved in immune defense and regulation. Our cross-sectional studies indicated that serum M2BP was a useful liver fibrosis biomarker for nonalcoholic fatty liver disease (NAFLD). In this study, we conducted a 7-year longitudinal study to investigate the significance of serum M2BP levels (baseline and at 7-year follow-up) and their relationships with other metabolic parameters of fatty liver disease.

View Article and Find Full Text PDF

Fucosylation is a type of glycosylation, a form of post-transcriptional regulation of proteins, involved in cancer and inflammation. It involves the attachment of a fucose residue to N-glycans, O-glycans, and glycolipids, which is catalyzed by a family of enzymes called fucosyltransferases (Futs). Among the many Futs, α-1,6-fucosyltransferase (Fut8) is the only enzyme that produces α-1,6-fucosylated oligosaccharides (core fucose).

View Article and Find Full Text PDF